{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:01:02Z","timestamp":1778400062928,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cmi.2019.02.020","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T19:13:21Z","timestamp":1550862801000},"page":"1233-1238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study"],"prefix":"10.1016","volume":"25","author":[{"given":"B.J.","family":"Webber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.P.","family":"Burganowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Colton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.J.","family":"Gambino-Shirley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.02.020_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.02.020_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.15585\/mmwr.mm6717e1","article-title":"Vital signs: trends in reported vectorborne disease cases \u2013 United States and territories, 2004\u20132016","volume":"67","author":"Rosenberg","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2019.02.020_bib3","first-page":"8","article-title":"Surveillance for vector-borne diseases among active and reserve component service members, U.S. Armed Forces, 2010-2016","volume":"25","author":"O\u2019Donnell","year":"2018","journal-title":"MSMR"},{"key":"10.1016\/j.cmi.2019.02.020_bib4","first-page":"2","article-title":"Lyme disease among U.S. military members, active and reserve component, 2001\u20132008","volume":"16","year":"2009","journal-title":"MSMR"},{"key":"10.1016\/j.cmi.2019.02.020_bib5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3201\/eid2207.151694","article-title":"Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of Lyme disease, United States","volume":"22","author":"Moore","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.02.020_bib6","doi-asserted-by":"crossref","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.02.020_bib7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2019.02.020_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jama.2018.10974","article-title":"Lyme disease in 2018: what is new (and what is not)","volume":"320","author":"Shapiro","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2019.02.020_bib9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/cid\/civ584","article-title":"Poor positive predictive value of Lyme disease serologic testing in an area of low disease incidence","volume":"61","author":"Lantos","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.02.020_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cmi.2017.08.025","article-title":"To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis","volume":"24","author":"Dessau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.02.020_bib11","first-page":"590","article-title":"Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease","volume":"44","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2019.02.020_bib12","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A\u00a0critical appraisal of \u201cchronic Lyme disease","volume":"357","author":"Feder","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.02.020_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00011-010-0209-1","article-title":"The positive predictive value of Borrelia burgdorferi serology in the light of symptoms of patients sent to an outpatient service for tick-borne diseases","volume":"59","author":"Lakos","year":"2010","journal-title":"Inflamm Res"},{"key":"10.1016\/j.cmi.2019.02.020_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/jamainternmed.2014.5426","article-title":"Neoplasms misdiagnosed as \u201cchronic Lyme disease","volume":"175","author":"Nelson","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2019.02.020_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.15585\/mmwr.mm6623a3","article-title":"Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme disease \u2013 United States","volume":"66","author":"Marzec","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2019.02.020_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/654808","article-title":"Death due to community-associated Clostridium difficile in a woman receiving prolonged antibiotic therapy for suspected Lyme disease","volume":"51","author":"Holzbauer","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.02.020_bib17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1469-0691.2011.03749.x","article-title":"High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice","volume":"18","author":"Seriburi","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.02.020_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jpeds.2016.04.004","article-title":"False positive Lyme disease IgM immunoblots in children","volume":"174","author":"Lantos","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cmi.2019.02.020_bib19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of Lyme borreliosis","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.02.020_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jme\/tjv237","article-title":"County-scale distribution of Ixodes scapularis and Ixodes pacificus (Acari: ixodidae) in the continental United States","volume":"53","author":"Eisen","year":"2016","journal-title":"J\u00a0Med Entomol"},{"key":"10.1016\/j.cmi.2019.02.020_bib21","series-title":"6490.02E: comprehensive health surveillance","author":"Department of Defense Directive","year":"2017"},{"key":"10.1016\/j.cmi.2019.02.020_bib22","series-title":"Armed Forces reportable medical events: guidelines and case definitions","year":"2017"},{"key":"10.1016\/j.cmi.2019.02.020_bib23","series-title":"Case definition","year":"2017"},{"key":"10.1016\/j.cmi.2019.02.020_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ajcp\/aqx153","article-title":"Lyme disease testing in a high-incidence state: clinician knowledge and patterns","volume":"149","author":"Conant","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cmi.2019.02.020_bib25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ttbdis.2014.01.008","article-title":"Healthcare providers\u2019 experience with Lyme and other tick-borne diseases","volume":"5","author":"Brett","year":"2014","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.cmi.2019.02.020_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.1994.03510300066040","article-title":"The use of serologic tests for Lyme disease in a prepaid health plan in California","volume":"271","author":"Ley","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2019.02.020_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe","volume":"17","author":"Stanek","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.02.020_bib28","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed Lyme disease, United States, 2005\u20132010","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.02.020_bib29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.02.020_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/jcm.33.2.419-427.1995","article-title":"Immunoblot interpretation criteria for serodiagnosis of early Lyme disease","volume":"33","author":"Engstrom","year":"1995","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.02.020_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9343(99)00046-7","article-title":"Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States","volume":"106","author":"Hilton","year":"1999","journal-title":"Am J Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19300862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19300862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:23:37Z","timestamp":1761117817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19300862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1198743X19300862"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.02.020","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}